Syndicated Research Studies

In Vitro Diagnostics Market Summary The global in vitro diagnostics market was valued at USD 108.30 billion in 2024 and is anticipated to reach USD 150.13 billion by 2030, progressing at a CAGR of 5.62% from 2025 to 2030. This steady expansion reflects the growing worldwide need for diagnostic solutions that are accurate, rapid, and increasingly personalized. Rising incidence of chronic and infectious diseases, continuous technological breakthroughs, and a healthcare shift toward early detection and preventive care are central forces behind this growth. The integration of digital health platforms, artificial intelligence, and advanced analytics into diagnostic workflows is enhancing precision, efficiency, and clinical decision-making. Simultaneously, expansion of point-of-care (POC) testing, personalized medicine initiatives, emerging economies, and heightened global pandemic preparedness are strengthening adoption across healthcare systems. A significant driver remains the growing...

In Vitro Diagnostics Industry Overview The global in vitro diagnostic market size was valued at USD 111.67 billion in 2021 and is projected to grow at a compound annual growth rate (CAGR) of 0.2% from 2022 to 2030. The growth can be attributed to the increasing adoption of IVDowing to the rise in testing due to the pandemic. The development of automated IVD systems for laboratories and hospitals to provide efficient, accurate, and error-free diagnoses is expected to fuel the market growth. The rising number of IVD (in vitro diagnostics ) products being launched by key players is also fueling the growth of the market. IVD products with molecular diagnostic capabilities deliver effective and accurate results.  In May 2021, an ultrasensitive molecular test was developed by the University of California. This test is based on a chip technology that can detect the presence of influenza A and SARS-CoV-2 antigens. The test is under further study for conversion into a Point-of-Care (POC)...